Nucleic Acid Amplification Testing (NAAT) Market

Executive Summary

Nucleic Acid Amplification Testing (NAAT) Market was valued at US $7,026.92 million in 2021 and is projected to grow at 13.35% CAGR over the forecast period to reach US $14,905.37 million by 2027. Nucleic Acid Amplification Testing (NAAT) Market represented US $1,557.95 million opportunity over 2019-2021 and estimated to create US $7,878.45 million opportunity in 2027 over 2021.

Nucleic Acid Amplification Testing (NAAT) from Consainsights analyses the Nucleic Acid Amplification Testing (NAAT) Market in the Life Sciences industry over the forecast period to 2027.

Nucleic Acid Amplification Testing (NAAT) research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Nucleic Acid Amplification Testing (NAAT) segmentation includes Technique, Application and Geography.

Based on the Technique, the Nucleic Acid Amplification Testing (NAAT) analysis covers Target Amplification, Probe Amplification, Signal Amplification.

In Technique segment, Target Amplification segment has highest cagr growth of 11.78%.

Based on the Application, the Nucleic Acid Amplification Testing (NAAT) analysis covers Infectious Disease, Cancer, Other Applications.

In Application segment, Infectious Disease segment has highest cagr growth of 11.78%.

Based on the region, the Nucleic Acid Amplification Testing (NAAT) analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Grifols SA, Hoffmann-La Roche Ltd, Hologic Inc., Illumina Inc., Siemens Healthcare GmbH, Beckman Coulter Inc. (Danaher Corporation), Cepheid and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Technique

Introduction

In 2021, Target Amplification segment has the highest revenue of US $4,134.66 million and is expected to grow at CAGR of 11.78% by 2027 Target Amplification segment has highest cagr growth of 11.78%.

Target Amplification

Target Amplification segment was valued at US $3,217.96 million in 2019 and is projected to grow at 11.78% CAGR over the forecast period to reach US $8,770.36 million by 2027. Target Amplification segment represented US $916.70 million opportunity over 2019-2021 and estimated to create US $4,635.70 million opportunity in 2027 over 2021.

Probe Amplification

Probe Amplification segment was valued at US $2,196.80 million in 2019 and is projected to grow at 11.78% CAGR over the forecast period to reach US $5,987.24 million by 2027. Probe Amplification segment represented US $625.80 million opportunity over 2019-2021 and estimated to create US $3,164.64 million opportunity in 2027 over 2021.

Signal Amplification

Signal Amplification segment was valued at US $54.22 million in 2019 and is projected to grow at 11.78% CAGR over the forecast period to reach US $147.78 million by 2027. Signal Amplification segment represented US $15.45 million opportunity over 2019-2021 and estimated to create US $78.11 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Infectious Disease segment has the highest revenue of US $4,308.05 million and is expected to grow at CAGR of 11.78% by 2027 Infectious Disease segment has highest cagr growth of 11.78%.

Infectious Disease

Infectious Disease segment was valued at US $3,352.90 million in 2019 and is projected to grow at 11.78% CAGR over the forecast period to reach US $9,138.14 million by 2027. Infectious Disease segment represented US $955.14 million opportunity over 2019-2021 and estimated to create US $4,830.10 million opportunity in 2027 over 2021.

Cancer

Cancer segment was valued at US $1,263.91 million in 2019 and is projected to grow at 11.78% CAGR over the forecast period to reach US $3,444.72 million by 2027. Cancer segment represented US $360.05 million opportunity over 2019-2021 and estimated to create US $1,820.76 million opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $852.16 million in 2019 and is projected to grow at 11.78% CAGR over the forecast period to reach US $2,322.51 million by 2027. Other Applications segment represented US $242.75 million opportunity over 2019-2021 and estimated to create US $1,227.59 million opportunity in 2027 over 2021.